Stay updated on Abemaciclib in HR+, HER2+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Abemaciclib in HR+, HER2+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Abemaciclib in HR+, HER2+ Breast Cancer Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    No additions or deletions affecting the page's core function; the Study Details content appears unchanged between the old and new screenshots, including study title, eligibility criteria, and locations. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-03T21:30:27.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    39 days ago
    Change Detected
    Summary
    - Added a government-funding notice about potential delays and updated operating status guidance, and a major version bump to v3.2.0. - Removed the previous version tag v3.1.0.
    Difference
    1%
    Check dated 2025-10-06T07:53:00.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    - Updated version from v3.0.2 to v3.1.0. - No other content changes detected.
    Difference
    0.0%
    Check dated 2025-09-29T04:14:04.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    Localized the location to México (06700), bumped the version to v3.0.2, and removed the Back to Top link.
    Difference
    0.2%
    Check dated 2025-09-14T21:47:05.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.
    Difference
    0.1%
    Check dated 2025-09-07T18:12:11.000Z thumbnail image
  8. Check
    75 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of numerous facility names and locations, particularly in South Korea and various countries, while also removing several previously listed locations and related medical topics. Additionally, there is a new reference to a clinical study involving abemaciclib and trastuzumab in breast cancer treatment.
    Difference
    6%
    Check dated 2025-08-31T12:25:01.000Z thumbnail image

Stay in the know with updates to Abemaciclib in HR+, HER2+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Abemaciclib in HR+, HER2+ Breast Cancer Clinical Trial page.